This is a working overview of pentadecapeptide, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-05-25 and is reviewed periodically as new material appears.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
Laboratory research on this peptide has examined a wide and heterogeneous set of endpoints, including gastric ulcer models, tendon and ligament injury, wound closure, and intestinal inflammation. Most published findings come from rodent studies, and reported effect sizes are often large relative to controls. Because the compound has been tested across many unrelated injury models, the literature is frequently described as unusually broad for a single peptide. A substantial share of this work originates from a small number of research groups, which matters when assessing how widely results have been reproduced.
Evidence in humans is limited. Small clinical studies have examined the peptide in contexts such as ulcerative colitis and wound healing, but participant numbers are small and independent replication is scarce. It is not approved as a medicine by major regulatory agencies and is distributed mainly as a research material or compounded preparation. Long-term human safety data are not established, and questions about absorption through non-injected routes remain open rather than resolved. Claims about its effects are best read against these gaps.
BPC-157 is a synthetic peptide of fifteen amino acids, written in single-letter code as GEPPPGKPADDAGLV. The sequence corresponds to a partial fragment of a protein isolated from human gastric juice, described in early reports as body protection compound. The number 157 refers to a fragment designation in that work rather than to molecular mass. Initial descriptions appeared in the early 1990s, when the fragment was reported to protect gastrointestinal tissue in animal models. Commercial material is produced by solid-phase peptide synthesis rather than extracted from biological sources.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | computed for the free peptide |
| Molecular weight | about 1419 Da | monoisotopic mass near 1418.7 |
| Amino acid count | 15 | single chain, no disulfide bonds |
| Solubility | freely soluble in water | also dissolves in saline and phosphate buffer |
| Common synonyms | pentadecapeptide BPC, BPC 157 | fragment notation varies by source |
BPC-157 is a synthetic peptide built from fifteen amino acid residues. Its sequence comes from a larger protein fragment that researchers isolated from human gastric juice and described as a body protection compound. The fragment contains glycine, glutamic acid, five prolines, lysine, alanine, two aspartic acids, leucine, and valine. The number 157 in the name refers to the position of the stretch within the parent protein. Material used in laboratories is manufactured rather than extracted from stomach fluid.
The molecule carries 15 residues, a molar mass near 1419.5 g/mol, and the formula C62H98N16O22. Its structure features a proline-rich central region, a pair of adjacent aspartic acid residues, and no cysteine. The absence of cysteine means no disulfide bonds can form, which simplifies refolding and reconstitution. Suppliers usually ship the material as a freeze-dried powder that appears white to off-white. It dissolves readily in water and in saline solutions.
Published storage guidance follows general peptide practice rather than product-specific studies. The dry powder is typically kept at minus 20 degrees Celsius, away from light and moisture. Once reconstituted, solutions are generally refrigerated and used over days to weeks, because the aqueous environment slowly promotes hydrolysis and oxidation. Long-term data on degradation rates or breakdown products are sparse. Stated shelf lives from different producers vary widely, reflecting the absence of a shared reference standard.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
BPC-157 is a synthetic pentadecapeptide, meaning it consists of fifteen amino acids joined in a single chain. Its sequence is Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, a fragment corresponding to part of a larger protein found in human gastric juice. The peptide was first described in the 1990s by researchers in Zagreb who were studying gastric protective factors. It is not a naturally circulating hormone; it is a laboratory-made fragment derived from a stomach protein. The name is an abbreviation of body protection compound, with the number referring to the fragment's position in the source protein.
Most published work on BPC-157 comes from animal experiments rather than controlled human trials. Rodent models have examined its effects on gastrointestinal lesions, tendon and ligament injury, and blood vessel formation. These studies are often small and originate from a limited number of research groups, which affects how broadly the findings can be generalized. No large randomized human trial has been reported in the peer-reviewed literature. Discussion of the compound therefore rests largely on preclinical data, and questions about its effects in people remain open rather than settled.
Several mechanisms have been proposed to explain the activity observed in animal models. The most frequently cited involve signaling through vascular endothelial growth factor receptor 2 and modulation of the nitric oxide system. Researchers have also described interactions with protective pathways in the gut lining. These proposed mechanisms appear in the literature as hypotheses supported by preclinical observations, not as confirmed pathways in humans. The precise way the peptide produces its reported effects, and whether those effects carry across species, remain areas of active and unresolved investigation.
The ministry asked Indonesian citizens in Syria to keep calm and avoid getting out of their residence. Iran: The Ministry of Foreign Affairs said it had successfully evacuated Embassy personnel. Qatar: Foreign Minister Sheikh Mohammed bin Abdulrahman Al Thani criticized Assad for failing to use the previous lull in fighting to address Syria's underlying problems, stating: "Assad didn't seize this opportunity to start engaging and restoring his relationship with his people." Russia: Following Russia's call for its citizens to leave Syria, the Russian Embassy reported that all its staff members were safe following the fall of Damascus. Russia's Foreign Ministry stated that it was in contact with "all groups of the Syrian opposition", but played no role in negotiations. United Kingdom: Prime minister Keir Starmer said: "The Syrian people have suffered under Assad's barbaric regime for too long and we welcome his departure. Our focus is now on ensuring a political solution prevails, and peace and stability is restored". United Nations: Special Envoy for Syria Geir Pedersen called for urgent talks in Geneva to ensure an "orderly political transition" and the implementation of Security Council Resolution 2254. United States: The White House reported that "President Biden and his team are closely monitoring the extraordinary events in Syria and staying in constant touch with regional partners". In a televised speech addressed to Americans on 8 December 2024, U.S. president Joe Biden stated: "At long last, the Assad regime has fallen.
== Adverse effects == Neonatal circumcision is generally a safe, low-risk procedure when done by an experienced practitioner. The most common acute complications are excessive bleeding, infection and the removal of either too much or too little foreskin. These complications occur in approximately 0.13% of procedures, with bleeding being the most common acute complication in the United States. Minor complications are reported to occur in approximately 3.8%. Severe complications are rare. A specific complication rate is difficult to determine due to inconsistencies in classification. Complication rates are greater when the procedure is performed by an inexperienced operator, in unsterile conditions, and older patient age. In patients circumcised after the neonatal period and into adolescence, minor complication rates rise from approximately 1.5% in neonates to about 6% in adolescents. This increase is believed to be a result of increased foreskin vascularity. Significant acute complications happen rarely, occurring in about 1 in 500 newborn procedures in the United States. Severe to catastrophic complications, including death, are so rare that they are reported only as individual case reports. Where a Plastibell device is used, the most common complication is the retention of the device occurring in around 3.5% of procedures. Other possible complications include buried penis, chordee, phimosis, skin bridges, urethral fistulas, and meatal stenosis. These complications may be partly avoided with proper technique, and are often treatable without requiring surgical revision.
To expose the sensory tube feet and the eyespot to external stimuli, some starfish turn up the tips of their arms while moving. Having descended from bilateral organisms, starfish may move in a bilateral fashion, particularly when hunting or threatened. When crawling, certain arms act as the leading arms, while others trail behind. When a starfish finds itself upside down, two adjacent arms and an opposite arm press against the ground to lift up the two remaining arms; the opposite arm leaves the ground as the starfish turns over and recovers its normal stance. Apart from their function in locomotion, the tube feet act as accessory gills. The water vascular system serves to transport oxygen from, and carbon dioxide to, the tube feet and nutrients from the gut to the muscles involved in locomotion. Fluid movement is bidirectional and initiated by cilia.
== Mechanism of action == The primary mode of action of fluoroquinolones involves interaction with enzymes essential for major DNA functions such as replication, transcription and recombination. Difloxacin inhibits DNA gyrase (also known as Topoisomerase II), an enzyme required for negative super coiling during DNA replication Cell death can occur through the inability of bacteria to maintain the DNA super helical structure.
Sources: en.wikipedia.org
Advances in genomics, biotechnology, and biodetection, including major contributions to the complete sequencing of the human genome though the Joint Genome Institute and the development of rapid PCR (polymerase chain reaction) technology that lies at the heart of today's most advanced DNA detection instruments. Development and operation of the National Atmospheric Release Advisory Center (NARAC), which provides real-time, multi-scale (global, regional, local, urban) modeling of hazardous materials released into the atmosphere. Development of highest resolution global climate models and contributions to the Intergovernmental Panel on Climate Change which, together with former vice president Al Gore, was awarded the 2007 Nobel Peace Prize. Co-discoverers of new superheavy elements 113, 114, 115, 116, 117, and 118. Invention of new healthcare technologies, including a microelectrode array for construction of an artificial retina, a miniature glucose sensor for the treatment of diabetes, and a compact proton therapy system for radiation therapy. On July 17, 2009 LLNL announced that the Laboratory had received eight R&D 100 Awards – more than it had ever received in the annual competition. The previous LLNL record of seven awards was reached five times – in 1987, 1988, 1997, 1998 and 2006. Also known as the "Oscars of invention", the awards are given each year for the development of cutting-edge scientific and engineering technologies with commercial potential. The awards raise LLNL's total number of awards since 1978 to 129.
Ranged combat is first-person, with character points assigned to the firearms skill determining the shot's accuracy and how long it takes to target an opponent. Melee combat is third-person, with access to weapons such as katanas and sledgehammers for melee combat, or pistols, crossbows, and flamethrowers for firearm combat. If a player sneaks up on an opponent, they can perform an instant kill; weapons provide unique instant kill animations. The player can block attacks manually or automatically by leaving their character idle. They can use stealth in missions by sneaking past guards and security cameras, picking locks, and hacking computers to locate alternative routes. Each clan has specific Disciplines, which can be used in combat and to create approaches to quests. Although some powers overlap clans, no two clans share the same three Disciplines. More physical vampires can enhance themselves to become fast and lethal killers or summon spirit allies to attack their foes; others can mentally dominate their targets to force their cooperation or render themselves invisible to hide from detection; and others can boil their opponent's blood from afar. The ability Blood Buff (which temporarily upgrades physical abilities) is common to all vampires. Several abilities can be active at the same time. Blood is a primary currency in Bloodlines, used to activate Disciplines and abilities.
== Research == SGLT2 inhibitors increase circulating ketone body concentrations. The cardioprotective effects of SGLT2 inhibitors have been attributed to the elevated ketone levels. Gliflozins have been posited to exhibit protective effects on the heart, liver, kidneys, anti‐hyperlipidemic, anti‐atherosclerotic, anti‐obesity, anti‐neoplastic effects in in vitro, pre‐clinical, and clinical studies. Pleiotropic effects of this class have been attributed to a variety of its pharmacodynamic actions such as natriuresis, hemoconcentration, deactivation of renin–angiotensin–aldosterone system, ketone body formation, alterations in energy homeostasis, glycosuria, lipolysis, anti‐inflammatory, and antioxidative actions. SGLT2 inhibitors have shown beneficial effects on liver function in clinical trials on individuals with NAFLD and type 2 diabetes, and also on those without type 2 diabetes. SGLT2 inhibitors also modified the adverse effects of ozone in heart failure, indicating a potential cardioprotective role. SGLT2 inhibitors have anti-inflammatory and immunomodulatory effects through pathways such as NF-κB, AMPK/mTOR, and JAK/STAT.
Sources: en.wikipedia.org
Of the major groups of teleosts, the Elopomorpha, Clupeomorpha and Percomorpha (perches, tunas and many others) all have a worldwide distribution and are mainly marine; the Ostariophysi and Osteoglossomorpha are worldwide but mainly freshwater, the latter mainly in the tropics; the Atherinomorpha (guppies, etc.) have a worldwide distribution, both fresh and salt, but are surface-dwellers. In contrast, the Esociformes (pikes) are limited to freshwater in the Northern Hemisphere, while the Salmoniformes (salmon, trout) are found in both Northern and Southern temperate zones in freshwater, some species migrating to and from the sea. The Paracanthopterygii (cods, etc.) are Northern Hemisphere fish, with both salt and freshwater species. Some teleosts are migratory; certain freshwater species move within river systems on an annual basis; other species are anadromous, spending their lives at sea and moving inland to spawn, salmon and striped bass being examples. Others, exemplified by the eel, are catadromous, doing the reverse. The fresh water European eel migrates across the Atlantic Ocean as an adult to breed in floating seaweed in the Sargasso Sea. The adults spawn here and then die, but the developing young are swept by the Gulf Stream towards Europe. By the time they arrive, they are small fish and enter estuaries and ascend rivers, overcoming obstacles in their path to reach the streams and ponds where they spend their adult lives. Teleosts including the brown trout and the scaly osman are found in mountain lakes in Kashmir at altitudes as high as 3,819 m (12,530 ft).
=== Diabulimia === Diabulimia is caused by a range of factors relating to body image, the regular use of insulin, and emotional well-being. The long-term management of type 1 diabetes often involves dietary restrictions for control of blood sugar level, which can raise a negative attention to diet. There is often a focus on the fact that insulin can cause weight gain, and that not using insulin can cause weight loss. For example, a person with type 1 diabetes may have experienced weight loss before the diagnosis, followed by weight gain when beginning treatment with insulin. This may lead to increased body dissatisfaction and preoccupation with weight loss. This increases the risk of eating disorders such as anorexia nervosa and bulimia nervosa. The vast majority of people with diabulimia are aware of the negative side effects that hyperglycemia can cause. Skipping insulin can lead to weight loss without side effects at first, but the risk of side effects gets progressively worse - by this time, it is more difficult to change behavior. Weight gain can cause individuals to fear insulin as it is often seen as the root of their low self-esteem. Low self-esteem can lead to depression or anxiety about body image that contributes to difficulty with diabetes management. Often, individuals often think diabulimia is less common than it is and do not know how difficult it is to overcome. Unlike vomiting or starving, there is sometimes no clear action or willpower involved. Often, individuals will refuse to believe in the diagnosis or the long-term effects.
The abundance of 60Ni present in extraterrestrial material may bring further insight into the origin and early history of the Solar System. The most abundant iron isotope 56Fe is of particular interest to nuclear scientists because it represents the most common endpoint of nucleosynthesis. Since 56Ni (14 alpha particles) is easily produced from lighter nuclei in the alpha process in nuclear reactions in supernovae (see silicon burning process), it is the endpoint of fusion chains inside extremely massive stars. Although adding more alpha particles is possible, but nonetheless the sequence does effectively end at 56Ni because conditions in stellar interiors cause the competition between photodisintegration and the alpha process to favor photodisintegration around 56Ni. This 56Ni, which has a half-life of about 6 days, is created in quantity in these stars, but soon decays by two successive positron emissions within supernova decay products in the supernova remnant gas cloud, first to radioactive 56Co, and then to stable 56Fe. As such, iron is the most abundant element in the core of red giants, and is the most abundant metal in iron meteorites and in the dense metal cores of planets such as Earth. It is also very common in the universe, relative to other stable metals of approximately the same atomic weight. Iron is the sixth most abundant element in the universe, and the most common refractory element.
She contributed to laboratory stewardship efforts which are part of reducing unnecessary health care. She was president of the Academy of Clinical Laboratory Physicians and Scientists and vice president of the North American Specialized Coagulation Laboratory Association (NASCOLA). She served on the ASH education committee, AHA thrombosis study group, NHLBI project review committee, and ISTH international advisory board.
Sources: en.wikipedia.org
The sequence corresponds to a fragment of a protein found in human gastric juice, so related sequences are natural. The isolated fifteen-amino-acid peptide supplied for research is produced synthetically. Whether the free fragment circulates naturally in humans has not been settled.
In most jurisdictions it is not an approved medicine and is handled as a research material. Import and sale rules differ by country, and some regulators have placed it in categories that restrict human use. Status can change, so current local rules apply.
Rodent models dominate, particularly rats with induced gastric lesions, tendon injury, or vascular disruption. These designs allow controlled comparison but differ anatomically and metabolically from humans. Results from such models are commonly cited as preliminary.
It is a synthetic fifteen-amino-acid peptide whose sequence matches part of a protein found in human gastric juice. It is made by chemical synthesis, not purified from tissue. The name derives from an early fragment label, not from a molecular weight.